Shanrong Biotechnology Corp.
SRBT
$0.13
-$0.03-19.03%
OTC PK
| 12/31/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -49.84% | -- | 296.77% | -- | 78.03% |
| Total Receivables | -36.14% | -- | 256.98% | -- | -85.16% |
| Inventory | -- | -- | -- | -- | 0.00% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 20.25% | -- | 0.00% | -- | -- |
| Total Current Assets | -58.31% | -- | 60.25% | -- | -71.01% |
|
|
|||||
| Total Current Assets | -58.31% | -- | 60.25% | -- | -71.01% |
| Net Property, Plant & Equipment | -36.21% | -- | -30.07% | -- | -25.98% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -52.93% | -- | 22.27% | -- | -65.96% |
|
|
|||||
| Total Accounts Payable | 19.41% | -- | 481.05% | -- | 161.02% |
| Total Accrued Expenses | 42.55% | -- | 128.54% | -- | 384.78% |
| Short-term Debt | -30.50% | -- | 27.50% | -- | 100.41% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.81% | -- | -8.78% | -- | 72.34% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -99.99% |
| Total Other Current Liabilities | -- | -- | -- | -- | -99.99% |
| Total Current Liabilities | 0.99% | -- | 65.36% | -- | 59.01% |
|
|
|||||
| Total Current Liabilities | 0.99% | -- | 65.36% | -- | 59.01% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -30.50% | -- | 27.50% | -- | 100.41% |
| Capital Leases | -91.92% | -- | -63.78% | -- | -65.08% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.82% | -- | 58.87% | -- | 53.20% |
|
|
|||||
| Common Stock & APIC | 328.37% | -- | 61.31% | -- | 10.93% |
| Retained Earnings | -95.05% | -- | -72.81% | -- | -103.72% |
| Treasury Stock & Other | 127.50% | -- | 483.33% | -- | -- |
| Total Common Equity | -8.99% | -- | -63.52% | -- | -150.33% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -8.99% | -- | -63.52% | -- | -150.33% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -8.99% | -- | -63.52% | -- | -150.33% |
|
|
|||||